Belgrave Bloodstock Limited 06778682 true 2025-01-01 2025-12-31 2025-12-31 The principal activity of the company is that of a dormant company. Digita Accounts Production Advanced 6.30.9574.0 true Mr N H D Ryder 06778682 2025-01-01 2025-12-31 06778682 2025-12-31 06778682 core:ShareCapital 2025-12-31 06778682 core:CurrentFinancialInstruments 2025-12-31 06778682 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 06778682 bus:FRS102 2025-01-01 2025-12-31 06778682 bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 06778682 bus:FullAccounts 2025-01-01 2025-12-31 06778682 bus:RegisteredOffice 2025-01-01 2025-12-31 06778682 bus:Director2 2025-01-01 2025-12-31 06778682 bus:EntityHasNeverTraded 2025-01-01 2025-12-31 06778682 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 06778682 countries:EnglandWales 2025-01-01 2025-12-31 06778682 2024-12-31 06778682 core:ShareCapital 2024-12-31 06778682 core:CurrentFinancialInstruments 2024-12-31 06778682 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 iso4217:GBP

Registration number: 06778682

Belgrave Bloodstock Limited
Annual Report and Unaudited Financial Statements
for the Year Ended 31 December 2025

Belgrave Bloodstock Limited

Profit and Loss Account for the Year Ended 31 December 2025

The company has not traded during the year. During this year, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

Belgrave Bloodstock Limited

(Registration number: 06778682)
Balance Sheet as at 31 December 2025

| Note | 2025 £ | 2024 £
Current assets |  |  |
Debtors | 3 | 2 | 2
Capital and reserves |  |  |
Called up share capital |  | 2 | 2
Shareholders' funds |  | 2 | 2

For the financial year ending 31 December 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.

Approved and authorised by the director on 8 April 2026

......................................... Mr N H D Ryder Director

Belgrave Bloodstock Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
2 Old Bath Road
Newbury
Berkshire
RG14 1QL
England

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3 | Debtors

Current | 2025 £ | 2024 £
Other debtors | 2 | 2
| 2 | 2